Kimberlee Drapkin Cobleigh's most recent trade in Kineta Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kineta Inc | Drapkin Cobleigh Kimberlee | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2025 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kineta Inc | Kimberlee Drapkin Cobleigh | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2025 | 13,794 | 0 | - | - | Common Stock | |
| Kineta Inc | Kimberlee Cobleigh Drapkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2025 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Kineta Inc | Kimberlee Cobleigh Drapkin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 23 Jun 2025 | 12,500 | 12,500 | - | 0.6 | 7,638 | Common Stock |
| Kineta Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 6,000 | 13,794 | - | 0 | Common Stock | |
| Kineta Inc | Kimberlee Cobleigh Drapkin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.26 per share. | 23 Jun 2025 | 4,706 | 7,794 | - | 0.3 | 1,224 | Common Stock |
| LENZ Therapeutics Inc. | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| Climb Bio Inc. | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 12,800 | 12,800 | - | 0 | Common Stock | |
| Climb Bio Inc. | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Kineta Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Kineta Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 50,000 | 50,000 | - | - | Stock Option Grant (right to buy) |